Oleksandr Sverdlov

Handling Covariates in the Design of Clinical Trials

William F. Rosenberger, Oleksandr Sverdlov · Statistical Science · 2008 · 178 citations · Full text

Patient Selection, Clinical Endpoint, Statistics Community +18

A roadmap to using randomization in clinical trials

Vance W. Berger, Louis Bour, Kerstine Carter et al. · BMC Medical Research Methodology · 2021 · 110 citations · Full text

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers

Gary Tong, Junsheng Wang, Oleksandr Sverdlov et al. · Clinical Therapeutics · 2012 · 65 citations

Single-ascending Dose Study, Therapeutic Drug Monitoring, Pharmacology +9

Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat

Charles F. Albright, Randy Dockens, Jere E. Meredith et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 63 citations

A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects

Randy Dockens, Junsheng Wang, Lorna Castaneda et al. · Clinical Pharmacokinetics · 2012 · 47 citations

Drug Safety, Pharmacological Study, Elderly Subjects +6